Cargando…

Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses

Detalles Bibliográficos
Autores principales:	Dondi, Francesco, Albano, Domenico, Bertagna, Francesco, Treglia, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496815/ https://www.ncbi.nlm.nih.gov/pubmed/36139630 http://dx.doi.org/10.3390/cancers14184470

Ejemplares similares

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

Could [(18)F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
por: Dondi, Francesco, et al.
Publicado: (2022)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

Prevalence of Brain Incidental Lesions Detected by (68)Ga-DOTA Peptides PET/CT
por: Albano, Domenico, et al.
Publicado: (2022)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
por: Muoio, Barbara, et al.
Publicado: (2022)

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases
por: Dondi, Francesco, et al.
Publicado: (2022)

Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022)

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [(18)F]FDG PET/CT: A Comparison between Two PET/CT Scanners
por: Dondi, Francesco, et al.
Publicado: (2022)

PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review
por: Dondi, Francesco, et al.
Publicado: (2023)

Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Relationship between Baseline [(18)F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
por: Dondi, Francesco, et al.
Publicado: (2022)

(18)F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
por: Dondi, Francesco, et al.
Publicado: (2021)

Longitudinal Body Composition Changes Detected by [(18)F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

Incidental Unilateral Tuberculous Sacroiliitis Detected by (18)F-FDG PET/CT in a Patient with Abdominal Tuberculosis
por: Albano, Domenico, et al.
Publicado: (2017)

(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)

Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses
por: Treglia, Giorgio, et al.
Publicado: (2019)

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
por: Rizzo, Alessio, et al.
Publicado: (2022)

Diagnostic Performance of (18)F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis
por: Ballova, Veronika, et al.
Publicado: (2020)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

Prognostic Role of 2-[(18)F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative (131)I WBS and Positive 2-[(18)F]-FDG PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Role of (18)F-FDG PET/CT Radiomics Features in the Differential Diagnosis of Solitary Pulmonary Nodules: Diagnostic Accuracy and Comparison between Two Different PET/CT Scanners
por: Albano, Domenico, et al.
Publicado: (2021)

Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[(18)F]-FDG PET/CT in Elderly Mantle Cell Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Thyroid metastasis from lung carcinoid detected by (68)Ga-DOTATOC PET/CT
por: Albano, Domenico, et al.
Publicado: (2021)

Comparison between Two Different Scanners for the Evaluation of the Role of (18)F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas
por: Dondi, Francesco, et al.
Publicado: (2022)

Hepatosplenic Candidiasis Detected by (18)F-FDG-PET/CT
por: Albano, Domenico, et al.
Publicado: (2016)

The role of Tg kinetics in predicting 2-[(18)F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan
por: Albano, Domenico, et al.
Publicado: (2021)

(18)F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis
por: Ferrari, Matteo, et al.
Publicado: (2021)

Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis
por: Treglia, Giorgio, et al.
Publicado: (2023)

Diagnostic Role of (18)F-PSMA-1007 PET/CT in Prostate Cancer Staging: A Systematic Review
por: Awenat, Salam, et al.
Publicado: (2021)

Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [(18)F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
por: Albano, Domenico, et al.
Publicado: (2020)

FAPI PET/CT in infectious, inflammatory, and rheumatological diseases: “watch it like a hawk” or “one swallow does not make a summer”?
por: Treglia, Giorgio, et al.
Publicado: (2023)

Accuracy of (68)Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
por: Barbosa, Álan Roger Gomes, et al.
Publicado: (2022)

Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
por: Glemser, P. A., et al.
Publicado: (2022)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
por: Combes, Alexander D., et al.
Publicado: (2022)

Ga-68-PSMA PET/CT ? or PET/MRI ?, Mp-MRI ? in diagnosis and radiotherapy planning in a patient with prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2020)

Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
por: Scobioala, Sergiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ro5grmhhd59pe990hvk5ru8dem